Total Clarity Wealth Management, Inc. Leap Therapeutics, Inc. Transaction History

Total Clarity Wealth Management, Inc.

  • $296 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
BUY
$0.96 - $1.91 $4,896 - $9,741
5,100 New
5,100 $6,000
Q1 2022

Apr 29, 2022
SELL
$1.6 - $3.35 $24,160 - $50,585
-15,100 Closed
0 $0
Q4 2021

Feb 03, 2022
BUY
$2.08 - $3.65 $5,408 - $9,490
2,600 Added 20.8%
15,100 $49,000
Q3 2021

Oct 21, 2021
BUY
$1.35 - $4.01 $16,875 - $50,125
12,500 New
12,500 $50,000

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0
View Full List

About LEAP THERAPEUTICS, INC.

LPTX Quotes by TradingView
  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $275M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Total Clarity Wealth Management, Inc. Portfolio

Follow Total Clarity Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email